Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial. Aaronson ST, van der Vaart A, Miller T, LaPratt J, et al. Am J Psychiatry 2025;182:104-113.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Aaronson ST, van der Vaart A, Miller T, LaPratt J, et al. Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial. Am J Psychiatry 2025;182:104-113.
PMID: 39741440